Rare diseases
Investigational molecules
Locations
Back to Hungary13 clinical trials in Vac, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
HungaryA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
HungaryStudy on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
HungaryStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
HungaryComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
HungaryStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
HungaryStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
HungaryStudy on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
HungaryStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
HungaryStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
HungaryStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
HungaryStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on Ulcerative Colitis and Crohn's Disease treatments, evaluating innovative therapies including zasocitinib and mirikizumab for long-term disease management.
Multiple studies examining both short-term and extended treatment outcomes for inflammatory bowel conditions.
Research initiatives targeting acute ischemic stroke and migraine treatments, including studies of innovative compounds like redasemtide and atogepant.
Focused investigations on reducing stroke risk and improving acute migraine management outcomes.
Development of novel treatments including biosimilar studies and evaluation of new molecular entities for chronic inflammatory conditions.
Comprehensive assessment of treatment efficacy and safety profiles across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
